Literature DB >> 25933501

Vitamin E therapy for NAFLD/NASH.

Masashi Yoneda1, Takenao Hasegawa2, Ken Sato1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25933501     DOI: 10.1016/j.nut.2014.08.007

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


× No keyword cloud information.
  6 in total

1.  Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease's Statin Therapy in Men.

Authors:  Nikola Hadzi-Petrushev; Katerina Dimovska; Nikola Jankulovski; Dine Mitrov; Mitko Mladenov
Journal:  Adv Pharmacol Sci       Date:  2018-05-17

Review 2.  The Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement?

Authors:  Anna Licata; Maddalena Zerbo; Silvia Como; Marcella Cammilleri; Maurizio Soresi; Giuseppe Montalto; Lydia Giannitrapani
Journal:  Nutrients       Date:  2021-11-10       Impact factor: 5.717

Review 3.  Current and Emerging Approaches for Hepatic Fibrosis Treatment.

Authors:  Jingguo Li; Biguang Tuo
Journal:  Gastroenterol Res Pract       Date:  2021-07-16       Impact factor: 2.260

4.  Severe Alcoholic Hepatitis Effectively Treated with Vitamin E as an Add-on to Corticosteroids.

Authors:  Yuichi Miyashima; Michihiko Shibata; Yuichi Honma; Hidehiko Matsuoka; Masaaki Hiura; Shintaro Abe; Masaru Harada
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

Review 5.  Current and future pharmacological therapies for NAFLD/NASH.

Authors:  Yoshio Sumida; Masashi Yoneda
Journal:  J Gastroenterol       Date:  2017-12-16       Impact factor: 7.527

6.  PPAR δ inhibition protects against palmitic acid-LPS induced lipidosis and injury in cultured hepatocyte L02 cell.

Authors:  Yi Li; Chenwei Wang; Jiyuan Lu; Ke Huang; Yu Han; Junlin Chen; Yan Yang; Bin Liu
Journal:  Int J Med Sci       Date:  2019-10-21       Impact factor: 3.642

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.